Form 4 for OGN Organon & Co.
Accepted 2023-04-04 00:00:00 ET · period of report 2023-03-31 · accession 0001209191-23-023087 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-04-04 | 2023-03-31 | OGN | WALSH MATTHEW M | CFO | F - Tax | $23.09 | -2,656 | 36.8K | -7% | -$61.3K |
| D | 2023-04-04 | 2023-03-31 | OGN | WALSH MATTHEW M | CFO | M - OptEx | $0.00 | +7,753 | 39.5K | +24% | $0 |
| DM | 2023-04-04 | 2023-03-31 | OGN | WALSH MATTHEW M | CFO | A - Grant | $0.00 | +165.9K | 129.8K | New | $0 |
| D | 2023-04-04 | 2023-03-31 | OGN | WALSH MATTHEW M | CFO | M - OptEx | $0.00 | -7,753 | 15.5K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-31 | F | D | 2,656 | $23.09 | 36,803 | D | — | — | |
| 2 | Common | Common Stock | 2023-03-31 | M | A | 7,753 | $0.00 | 39,459 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2023-03-31 | A | A | 36,139 | $0.00 | 36,139 | D | — · 2024-03-31 to 2026-03-31 | 36,139 Common Stock | (F3) The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon common stock for each RSU. (F4) These RSUs vest and are distributed as shares of Organon common stock in three equal installments on March 31, 2024, March 31, 2025 and March 31, 2026. |
| 4 | Derivative | Stock Option (right to buy) | 2023-03-31 | A | A | 129,770 | $0.00 | 129,770 | D | $23.52 · 2024-03-31 to 2033-03-31 | 129,770 Common Stock | (F5) The Reporting Person was granted stock options, which vest and become exercisable in three equal installments on March 31, 2024, March 31, 2025 and March 31, 2026. |
| 5 | Derivative | Restricted Stock Units | 2023-03-31 | M | D | 7,753 | $0.00 | 15,507 | D | — · — to — | 7,753 Common Stock | (F1) Each Restricted Stock Unit converts into one share of Organon & Co. ("Organon") common stock. (F2) On March 31, 2023, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on March 31, 2024 and March 31, 2025. |